1921
Volume 89, Issue 4
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

Deployment of oral cholera vaccine (OCV) on the Island of Hispaniola has been considered since the emergence of the disease in October of 2010. At that time, emergency response focused on the time-tested measures of treatment to prevent deaths and sanitation to diminish transmission. Use of the limited amount of vaccine available in the global market was recommended for demonstration activities, which were carried out in 2012. As transmission continues, vaccination was recommended in Haiti as one component of a comprehensive initiative supported by an international coalition to eliminate cholera on the Island of Hispaniola. Leveraging its delivery to strengthen other cholera prevention measures and immunization services, a phased OCV introduction is pursued in accordance with global vaccine supply. Not mutually exclusive or sequential deployment options include routine immunization for children over the age of 1 year and campaigns in vulnerable metropolitan areas or rural areas with limited access to health services.

[open-access] This is an Open Access article distributed under the terms of the American Society of Tropical Medicine and Hygiene's Re-use License which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.13-0200
2013-10-09
2017-11-24
Loading full text...

Full text loading...

/deliver/fulltext/14761645/89/4/682.html?itemId=/content/journals/10.4269/ajtmh.13-0200&mimeType=html&fmt=ahah

References

  1. Pan American Health Organization, 2013. Atlas of Cholera Outbreak in La Hispaniola, 2010–2013. Available at: http://new.paho.org/hq/images/Atlas_IHR/CholeraHispaniola/atlas.html. Accessed April 18, 2013.
  2. Barzilay EJ, Schaad N, Magloire R, Mung KS, Boncy J, Dahourou GA, Mintz ED, Steenland MW, Vertefeuille JF, Tappero JW, , 2013. Cholera surveillance during the Haiti epidemic—the first 2 years. N Engl J Med 368: 599609.[Crossref]
  3. World Health Organization, 2010. Cholera vaccines: WHO position paper. Bull World Health Organ 85: 117128.
  4. Date KA, Vicari A, Hyde TB, Mintz E, Danovaro-Holliday MC, Henry A, Tappero JW, Roels TH, Abrams J, Burkholder BT, Ruiz-Matus C, Andrus J, Dietz V, , 2011. Considerations for oral cholera vaccine use during outbreak after earthquake in Haiti, 2010–2011. Emerg Infect Dis 17: 21052112.[Crossref]
  5. World Health Organization, 2013. A System for the Prequalification of Vaccines for UN Supply. Available at: http://www.who.int/immunization_standards/vaccine_quality/pq_system/en/. Accessed July 9, 2013.
  6. Sur D, Kanungo S, Sah B, Manna B, Ali M, Paisley AM, Niyogi SK, Park JK, Sarkar B, Puri MK, Kim DR, Deen JL, Holmgren J, Carbis R, Rao R, Nguyen TV, Han SH, Attridge S, Donner A, Ganguly NK, Bhattacharya SK, Nair GB, Clemens JD, Lopez AL, , 2011. Efficacy of a low-cost, inactivated whole-cell oral cholera vaccine: results from 3 years of follow-up of a randomized, controlled trial. PLoS Negl Trop Dis 5: e1289.[Crossref]
  7. Clemens J, Shin S, Ali M, , 2011. New approaches to the assessment of vaccine herd protection in clinical trials. Lancet Infect Dis 11: 482487.[Crossref]
  8. Ali M, Emch M, von Seidlein L, Yunus M, Sack DA, Rao M, Holmgren J, John D, Clemens JD, , 2005. Herd immunity conferred by killed oral cholera vaccines in Bangladesh: a reanalysis. Lancet 366: 4449.[Crossref]
  9. Khatib AM, Ali M, von Seidlein L, Kim DR, Hashim R, Reyburn R, Ley B, Thriemer K, Enwere G, Hutubessy R, Aguado MT, Kieny MP, Lopez AL, Wierzba TF, Ali SM, Saleh AA, Mukhopadhyay AK, Clemens J, Jiddawi MS, Deen J, , 2012. Effectiveness of an oral cholera vaccine in Zanzibar: findings from a mass vaccination campaign and observational cohort study. Lancet Infect Dis 12: 837844.[Crossref]
  10. Ali M, Sur D, You YA, Kanungo S, Sah B, Manna B, Puri M, Wierzba TF, Donner A, Nair GB, Bhattacharya SK, Dhingra MS, Deen JL, Lopez AL, Clemens J, , 2013. Herd protection by a bivalent killed whole-cell oral cholera vaccine in the slums of Kolkata, India. Clin Infect Dis 56: 11231131.[Crossref]
  11. Martin S, Costa A, Perea W, , 2012. Stockpiling oral cholera vaccine. Bull World Health Organ 90: 714.[Crossref]
  12. Population Division of the United Nations, 2011. World Population Prospects: The 2010 Revision. Available at: http://esa.un.org/wpp/Excel-Data/population.htm. Accessed April 17, 2013.
  13. WHO/UNICEF Joint Monitoring Programme for Water Supply and Sanitation, 2012. Haiti: Improved Water Coverage Estimates (1980–2010). Update March 2012. Available at: http://www.wssinfo.org/fileadmin/user_upload/resources/HTI_wat.pdf. Accessed September 4, 2012.
  14. WHO/UNICEF Joint Monitoring Programme for Water Supply and Sanitation, 2012. Haiti: Improved Sanitation Coverage Estimates (1980–2010). Update March 2012. Available at: http://www.wssinfo.org/fileadmin/user_upload/resources/HTI_san.pdf. Accessed September 4, 2012.
  15. WHO/UNICEF Joint Monitoring Programme for Water Supply and Sanitation, 2012. Dominican Republic: Improved Water Coverage Estimates (1980–2010). Update March 2012. Available at: http://www.wssinfo.org/fileadmin/user_upload/resources/DOM_wat.pdf. Accessed September 4, 2012.
  16. WHO/UNICEF Joint Monitoring Programme for Water Supply and Sanitation, 2012. Dominican Republic: Improved Sanitation Coverage Estimates (1980–2010). Update March 2012. Available at: http://www.wssinfo.org/fileadmin/user_upload/resources/DOM_san.pdf. Accessed September 4, 2012.
  17. UNICEF and World Health Organization, 2012. Progress on Drinking Water and Sanitation: 2012 Update. Available at: http://www.wssinfo.org/. Accessed May 24, 2013.
  18. International Organization for Migration, 2013. Displacement Tracking Matrix. Update 2013. Available at: http://iomhaitidataportal.info/dtm/. Accessed April 17, 2013.
  19. World Health Organization, 2013. Epidemic-Prone Diseases: Cholera. Available at: http://apps.who.int/gho/data/node.main.174. Accessed April 18, 2013.
  20. Jackson BR, Talkington DF, Pruckler JM, Fouche MDB, Lafosse E, Nygren B, Gómez GA, Dahourou GA, Archer WR, Payne AB, Hooper WC, Tappero JW, Derado G, Magloire R, Gerner-Smidt P, Freeman N, Boncy J, Mintz ED, the Cholera Serosurvey Working Group, , 2013. Sero-epidemiologic survey of cholera in Haiti to assess spectrum of illness and risk factors for severe disease. Am J Trop Med Hyg 89: 654664.[Crossref]
  21. Koelle K, Rodó X, Pascual M, Yunus M, Mostafa G, , 2005. Refractory periods and climate forcing in cholera dynamics. Nature 436: 696700.[Crossref]
  22. Rinaldo A, Bertuzzo E, Mari L, Righetto L, Blokesch M, Gatto M, Casagrandi R, Murray M, Vesenbeckh SM, Rodriguez-Iturbe I, , 2012. Reassessment of the 2010–2011 Haiti cholera outbreak and rainfall-driven multiseason projections. Proc Natl Acad Sci USA 109: 66026607.[Crossref]
  23. Pan American Health Organization, 2013. Millennium Water Association Joins Coalition for Water and Sanitation to Eliminate Cholera from Haiti. Available at: http://new.paho.org/colera/?p=367. Accessed April 17, 2013.
  24. Republic of Haiti, Ministry of Public Health and Population of Haiti and National Directorate for Water Supply and Sanitation, 2013. National Plan for the Elimination of Cholera in Haiti, 2013–2022. Available at: http://new.paho.org/hq/index.php?option=com_docman&task=doc_view&gid=20326&Itemid=270&lang=en. Accessed April 17, 2013.
  25. Rouzier V, Severe K, Jean Juste MA, Peck M, Perodin C, Severe P, Deschamps MM, Verdier RI, Prince S, Francois J, Cadet JR, Guillaume FD, Wright PF, Pape JW, , 2013. Cholera vaccination in urban Haiti. Am J Trop Med Hyg 89: 671681.[Crossref]
  26. Ivers LC, Teng JE, Lascher J, Raymond M, Weigel J, Victor N, Jerome JG, Hilaire IJ, Almazor CP, Ternier R, Cadet J, Francois J, Guillaume FD, Farmer PE, , 2013. Use of oral cholera vaccine in Haiti: a rural demonstration project. Am J Trop Med Hyg 89: 617624.[Crossref]
  27. Médecins Sans Frontières, 2012. Vaccinating Against Cholera in Guinea. Available at: http://www.doctorswithoutborders.org/press/release.cfm?id=6051&cat=press-release. Accessed April 17, 2103.
  28. Pan American Health Organization, 2012. Final Report of the Twentieth Meeting of the Technical Advisory Group on Vaccine-Preventable Diseases (TAG) of the Pan American Health Organization. Available at: http://new.paho.org/hq/index.php?option=com_docman&task=doc_download&gid=19263&Itemid=270&lang=en. Accessed April 17, 2013.
  29. Periago MR, Frieden TR, Tappero JW, De Cock KM, Aasen B, Andrus JK, , 2012. Elimination of cholera transmission in Haiti and the Dominican Republic. Lancet 379: e12e13.[Crossref]
  30. Moodley K, Hardie K, Selgelid MJ, Waldman RJ, Strebel P, Rees H, Durrheim DN, , 2013. Ethical considerations for vaccination programmes in acute humanitarian emergencies. Bull World Health Organ 91: 290297.[Crossref]
  31. Valera R, García HM, Jidy MD, Mirabal M, Armesto MI, Fando R, García L, Fernández R, Año G, Cedré B, Ramírez M, Bravo L, Serrano T, Palma S, González D, Miralles F, Medina V, Nuñez F, Plasencia Y, Martínez JC, Mandarioti A, Lugones J, Rodríguez BL, Moreno A, González D, Baro M, Solis RL, Sierra G, Barbera R, Domínguez F, Gutiérrez C, Kouri G, Campa C, Menéndez J, , 2009. Randomized, double-blind, placebo-controlled trial to evaluate the safety and immunogenicity of live oral cholera vaccine 638 in Cuban adults. Vaccine 27: 65646569.[Crossref]
  32. García HM, Thompson R, Valera R, Fando R, Fumane J, Jani I, Mirabal M, Armesto MI, Songane M, Luis S, Nzualo AM, Celeste J, Viegas S, Gudo ES, Melembe A, Bila D, Cemá C, Mabumo C, García L, Cedré B, Año G, Martínez JC, Mandarioti A, Lugones J, González D, Baró M, Hernández J, Talavera A, Solis RL, Sierra G, Barberá R, Domínguez F, Gutiérrez C, Campa C, Garrido I, Menéndez J, , 2011. A single dose of live-attenuated 638 Vibrio cholerae oral vaccine is safe and immunogenic in adult volunteers in Mozambique. Vaccimonitor 20: 18.
  33. PaxVax, 2012. Safety and Immunogenicity of the Live Oral Cholera Vaccine Candidate PXVX0200. Available at: http://clinicaltrials.gov/ct2/show/NCT01585181. Accessed April 17, 2013.
  34. Hashim R, Khatib AM, Enwere G, Park JK, Reyburn R, Ali M, Chang NY, Kim DR, Ley B, Thriemer K, Lopez AL, Clemens JD, Deen JL, Shin S, Schaetti C, Hutubessy R, Aguado MT, Kieny MP, Sack D, Obaro S, Shaame AJ, Ali SM, Saleh AA, von Seidlein L, Jiddawi MS, , 2012. Safety of the recombinant cholera toxin B subunit, killed whole-cell (rBS-WC) oral cholera vaccine in pregnancy. PLoS Negl Trop Dis 6: e1743.[Crossref]
  35. Jauregui B, Sinha A, Clark AD, Bolanos BM, Resch S, Toscano CM, Matus CR, Andrus JK, , 2011. Strengthening the technical capacity at country-level to make informed policy decisions on new vaccine introduction: lessons learned by PAHO's ProVac Initiative. Vaccine 29: 10991106.[Crossref]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.13-0200
Loading
/content/journals/10.4269/ajtmh.13-0200
Loading

Data & Media loading...

  • Received : 17 Apr 2013
  • Accepted : 26 Aug 2013

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error